JMN Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$739K Buy
5,183
+94
+2% +$14.3K 0.59% 35
2026
Q2
$798K Sell
5,089
-297
-6% -$44.5K 0.62% 39
2026
Q1
$823K Sell
5,386
-937
-15% -$144K 0.81% 23
2025
Q4
$872K Buy
+6,323
New +$828K 0.87% 21

Other funds holding NVS

JMN Financial's NVS Position: Q3 2026 in Review

JMN Financial increased its Novartis (NVS) stake by 1.8% in Q3 2026, buying an estimated $14.3K and bringing the position to 5,183 shares worth $739K. The position accounts for 0.59% of the portfolio, ranked #35.

JMN Financial first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $872K in Q4 2025. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • JMN Financial held 5,183 shares of Novartis worth $739K as of Q3 2026.
  • JMN Financial bought 94 Novartis shares in Q3 2026, an estimated $14.3K.
  • Novartis made up 0.59% of JMN Financial's portfolio in Q3 2026, its #35 holding.
  • JMN Financial first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • JMN Financial's Novartis position peaked at $872K in Q4 2025.
  • 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.